Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study

Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study

Abstract Background To evaluate the effectiveness of individualized-dose polyethylene glycol recombinant human growth hormone (PEG-rhGH) for short stature. Methods This real-world study enrolled children with short stature in 19 hospitals throughout China. They were treated with PEG-rhGH for 6 month...

Full description

Bibliographic Details
Main Authors: Jiajia Chen, Yan Zhong, Haiyan Wei, Shaoke Chen, Zhe Su, Lijun Liu, Liyang Liang, Ping Lu, Linqi Chen, Ruimin Chen, Shining Ni, Xinli Wang, Li Li, Yunfeng Wang, Xu Xu, Yanfeng Xiao, Hui Yao, Geli Liu, Runming Jin, Bingyan Cao, Di Wu, Chang Su, Wenjing Li, Miao Qin, Xiaoqiao Li, Xiaoping Luo, Chunxiu Gong
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Endocrine Disorders
Subjects:
Short stature
Children
Polyethylene glycol recombinant human growth hormone
Multicenter
Real-world study
Online Access:https://doi.org/10.1186/s12902-022-01101-8

Internet

https://doi.org/10.1186/s12902-022-01101-8

Similar Items